. . . "Sosna, Tom\u00E1\u0161" . "CZ - \u010Cesk\u00E1 republika" . "Nov\u00E9 postupy v l\u00E9\u010Db\u011B diabetick\u00E9 makulopatie" . "Kazuistiky v diabetologii" . . . . "Diabetick\u00E1 makulopatie p\u0159edstavuje nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinu slepoty u diabetik\u016F 2. typu. Zlat\u00FDm standardem l\u00E9\u010Dby byla t\u00E9m\u011B\u0159 40 rok\u016F laserov\u00E1 terapie, kter\u00E1 v\u0161ak nebyla v\u017Edy zcela \u00FAsp\u011B\u0161n\u00E1. V posledn\u00EDch letech se za\u010D\u00EDn\u00E1 \u00FAsp\u011B\u0161n\u011B kombinovat s intravitre\u00E1ln\u00ED aplikac\u00ED l\u00E1tek, kter\u00E9 p\u016Fsob\u00ED proti vaskul\u00E1rn\u00EDmu endotelov\u00E9mu r\u016Fstov\u00E9mu faktoru. Z\u00E1kladem l\u00E9\u010Dby v\u0161ak i nad\u00E1le z\u016Fst\u00E1v\u00E1 prevence ve form\u011B t\u011Bsn\u00E9 kompenzace rizikov\u00FDch faktor\u016F p\u0159edev\u0161\u00EDm hyperglykemie, hypertenze a dyslipidemie."@cs . "4"^^ . "RIV/00064190:_____/12:#0000420!RIV13-MZ0-00064190" . "RIV/00064190:_____/12:#0000420" . . . "10" . . "8"^^ . "3" . "2"^^ . . "Nov\u00E9 postupy v l\u00E9\u010Db\u011B diabetick\u00E9 makulopatie"@cs . . "New approaches in the treatment of diabetic maculopathy"@en . . "I, V" . . "1214-231X" . "New approaches in the treatment of diabetic maculopathy"@en . . "Nov\u00E9 postupy v l\u00E9\u010Db\u011B diabetick\u00E9 makulopatie" . "Diabetick\u00E1 makulopatie p\u0159edstavuje nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinu slepoty u diabetik\u016F 2. typu. Zlat\u00FDm standardem l\u00E9\u010Dby byla t\u00E9m\u011B\u0159 40 rok\u016F laserov\u00E1 terapie, kter\u00E1 v\u0161ak nebyla v\u017Edy zcela \u00FAsp\u011B\u0161n\u00E1. V posledn\u00EDch letech se za\u010D\u00EDn\u00E1 \u00FAsp\u011B\u0161n\u011B kombinovat s intravitre\u00E1ln\u00ED aplikac\u00ED l\u00E1tek, kter\u00E9 p\u016Fsob\u00ED proti vaskul\u00E1rn\u00EDmu endotelov\u00E9mu r\u016Fstov\u00E9mu faktoru. Z\u00E1kladem l\u00E9\u010Dby v\u0161ak i nad\u00E1le z\u016Fst\u00E1v\u00E1 prevence ve form\u011B t\u011Bsn\u00E9 kompenzace rizikov\u00FDch faktor\u016F p\u0159edev\u0161\u00EDm hyperglykemie, hypertenze a dyslipidemie." . "[6713AD3AB31A]" . . "\u0160vancarov\u00E1, Radka" . "154698" . "Nov\u00E9 postupy v l\u00E9\u010Db\u011B diabetick\u00E9 makulopatie"@cs . "bevacizumab; ranibizumab; intravitreal treatment; laser Therapy"@en . . . . "Diabetic maculopathy is the commonest cause of blindness patients with diabetes, type 2. The gold standard of treatment was nearly 40 years laser therapy, which was not always completely successful. In recent years, this therapy starts succeffully to combine with intravitreal application of substances that act against endothelial vascular growth factor. However, the mainstay of treatment still remains prevention in the form of compensation risk factors especially hyperglycemia, hypertension and dyslipidemia."@en .